In Charity News, Patient story

Just after graduating from university and ready to start his adult working life, the last thing that fit and healthy Kevin expected to face was the news that he had a brain tumour.

Bombshell news

Kevin describes this news as a bombshell, “and the fragments of the bomb ripped through every expectation and plan that I had”.

Despite feeling physically fine at the time of his diagnosis, news that he had a brain tumour meant that his goals were put on hold and a key part of his independence – Kevin was unable to drive following his diagnosis – lost. Feeling physically fine, of course, did not stop the worrying. After many sleepless nights imagining different scenarios resulting from his upcoming surgery, Kevin tried to push the bad thoughts to the back of his mind. He knew his family were constantly worrying, and he did not want to talk about his feelings with them. Worried about her son, Kevin’s mum Edna found brainstrust.

Don’t face living with a brain tumour alone. If you’re worried about talking about your brain tumour with loved ones, get in touch. We’re here to listen and can help you form a plan for talking to your family so they’re included, and you’re not isolated.

“A silver lining in an incredibly dark cloud”

When Edna would talk to him about brainstrust, Kevin would often “pretend to listen, as that’s what sons do!”. But she persisted seeking the charity’s support, and when Kevin was feeling increasingly frustrated on his brain tumour journey, brainstrust‘s help made all the difference:

“The long and short of it is our local hospital cancelled two operations, one of which I was gowned up for. brainstrust put us in contact with Dr McEvoy which was such a silver lining in what was becoming an incredibly dark cloud.

brainstrust have helped me incredibly, they’ve constantly supported my mum and always been there for her when she needed to speak to someone. They even supported us by paying for the private consultation, which was an incredible gesture that meant so much to me and my mum.”

Kevin continued on his brain tumour journey under Dr McEvoy, and has since had his surgery.

Going home minus a tumour

“Straight after the operation I was incredible groggy, I can still imagine feeling the stitched pull as I coughed of moved sharply which was the worst! I had impaired movement in the left side of my face and quite severe lack of movement in my left hand however I was convinced I would be fine (very frustrated nonetheless). I remember trying to brush my teeth with my lifeless limp hand and the occupational therapist supporting me and I somehow managed to stab myself in the eye, after that I felt so frustrated and disheartened but as the days went in the hand got better and better. By the time I was leaving hospital (12 days after surgery) I was as fit and well as I went home minus a tumour.

Since then I have been so well and had no side effects at all (touchwood). The whole experience has really made me appreciate the importance of health and shown me how moody I can be without physical exercise. As well as I recovered, I managed to break my collarbone on my first football game back, maybe I just love hospitals? Who knows!”

We can help you and your family cope with your brain tumour diagnosis so you can all thrive, not just survive. Get in touch – email us on hello@brainstrust.org.uk or call us on 01983 292 405.

shop instagram
Shopping to support people with a brain tumourCharity News
man on phone scaled
Living with a brain tumour: Money worriesBrain News

Introduction

The Brain Tumour Data Dashboard lets you explore up -to-date, population level data about the brain tumours diagnosed in England between 2013 and 2015. Using the drop down menus on the left you can select different groups of patients to view in the charts below. In these charts the number of patients for every 100 diagnoses is displayed as images of people. Patients have been grouped by date of diagnosis, type of tumour, age, gender, and region in England.

For each group of patients you can explore the different routes to diagnosis, the proportion of those who received chemotherapy or radiotherapy, as well as the survival of the patients within each group. For more information about what these metrics mean please see the glossary.

How to use

  1. Select the year of diagnosis using the drop down menu.
  2. Select your patient group of interest from the four drop down menus in the following order:
    1. Tumour group
    2. Age at diagnosis
    3. Region of England
    4. Gender of patient
  3. To view a second chart to compare different groups of patients, click the ‘compare’ button.The second chart will appear below the first chart.

*Note that the tool is best used on a laptop or tablet rather than a mobile phone*

Unavailable data

Some of the data in these charts is not available.There are two main reasons for this:

  1. How the data has been grouped

If you cannot select a patient group from the drop down menus, the data is unavailable because of how the data has been organised.

Public Health England has grouped the data like a branching tree. The bottom of the tree contains all the patients with brain tumours, and then each branch divides the data by a certain characteristics, like age, or location of tumour. But the data is divided in an order, starting with location of the tumour (endocrine or brain), then by age, region, and gender. Age is at the start because it makes a bigger difference to survival rates and treatment rates than gender or region. Sometimes, after the data has been split by type of tumour and age, there is not enough data to be split again. This is because to protect patient confidentiality groups cannot contain less than 100 patients. Because some groups cannot be split further, you cannot create ‘totals’ for everyone by region or gender. For example, you cannot see results for all ages by region, or all brain tumours by gender. If these totals were calculated and released, it might be possible to identify patients, which is why Public Health England cannot release this data.

  1. Statistical reasons and data availability

If you can select a patient group from the chart menus, but the chart does not display, the data is unavailable for one of several reasons:

  1. Data is not yet available for the selected year from Public Health England.
  2. Data is not available because the data quality is too poor to release this statistic.
  3. Data is not available as the statistic is not appropriate for this group.
  4. Data is not available because the standard error of the estimate was greater than 20% and so the estimate has been supressed.

Up to date brain tumour data

Brain tumour data may influence the decisions you make about your care. Data also helps you understand the bigger picture, or landscape, in which you find yourself.

Brain tumour data and statistics influence the focus, and work of organisations like brainstrust. The information helps us to understand the scale and impact of the problems we are setting out to solve.

This tool helps you understand the landscape in which you find yourself having been diagnosed with a brain tumour. This landscape can be particularly tricky to navigate as there are many different types of brain tumour, all of which have a different impact.

The information you see represents the most up-to-date, official, population level brain tumour data available for England. Over time we will be adding to the brain tumour data available and publishing reports, with recommendations, as a result of what we learn from this data.

The data behind this content has come from Public Health England’s National Cancer Registration and Analysis Service (NCRAS) and is a direct result of the ‘Get Data Out’ project.

This project provides anonymised population level brain tumour data for public use in the form of standard output tables, accessible here: http://cancerdata.nhs.uk/standardoutput

Incidence

The number or rate (per head of population) of new cases of a disease diagnosed in a given population during a specified time period (usually a calendar year). The crude rate is the total number of cases divided by the mid-year population, usually expressed per 100,000 population.

Malignant

Malignant tumours which grow by invasion into surrounding tissues and have the ability to metastasise to distant sites

Mortality

The number or rate (per head of population) of deaths in a given population during a specified time period (usually a calendar year). The crude rate is the total number of deaths divided by the mid-year population, usually expressed per 100,000 population.

Non-malignant

Not cancerous. Non-malignant tumours may grow larger but do not spread to other parts of the body.

Survival

The length of time from the date of diagnosis for a disease, such as cancer, that patients diagnosed with the disease are still alive. In a clinical trial, measuring the survival is one way to see how well a new treatment works. Also called ‘overall survival’ or ‘OS’.

Routes to Diagnosis

Under the ‘Routes to Diagnosis’ tab in the Brain Tumour Data Dashboard, you can explore the ways patients have been diagnosed with brain tumours. There are many ways, or routes, for cancers to be diagnosed in the NHS. A ‘route to diagnosis’ is the series of events between a patient and the healthcare system that leads to a diagnosis of cancer. The routes include:

  1. Two Week Wait

Patients are urgently referred by their GP for suspected cancer via the Two Week Wait system and are seen by a specialist within 2 weeks where they are diagnosed.

  1. GP referral

Diagnosis via a GP referral includes routine and urgent referrals where the patient was not referred under the Two Week Wait system.

  1. Emergency Presentation

Cancers can be diagnosed via emergency situations such as via A&E, emergency GP referral, emergency transfer or emergency admission.

  1. Outpatient

Outpatient cancer diagnoses include diagnoses via an elective route which started with an outpatient appointment that is either a self-referral or consultant to consultant referral. (It does not include those under the Two Week Wait referral system).

  1. Inpatient elective

Diagnosis via an inpatient elective route is where diagnosis occurs after the patient has been admitted into secondary care from a waiting list, or where the admission is booked or planned.

  1. Death Certificate Only

Diagnoses made by Death Certificate Only are made where there is no more information about the cancer diagnosis other than the cancer related death notifications. The date of diagnosis is the same as that of the date of death.

  1. Unknown

For some patients with a cancer diagnosis, there is no relevant data available to understand the route to diagnosis.

 

More information

If any of the statistical terms in this section of the brainstrust website are hard to understand, we recommend looking them up here:

Cancer Research UK’s Cancer Statistics Explained

http://www.cancerresearchuk.org/health-professional/cancer-statistics/cancer-stats-explained/statistics-terminology-explained#heading-Seven

If you are looking for help understanding terms relating specifically to brain tumours, and treatment, then the brainstrust glossary is available here:

https://www.brainstrust.org.uk/advice-glossary.php